Managing Early Dementia in 2025: An Interprofessional Clinical Skills Session Using the 5Ms Approach

Additional fee session

Sponsored by theNurses Section, Teachers Section, Pharmacists Section, Clinical Practice and Models of Care Committee and Education Committee

Moderator: Lisa Granville, MD, AGSF

Facilitators: Sharon A. Brangman, MD, AGSF; Abbie Eaton, PhD, MMS, PA-C; Cynthia Aguirre Valdivieso, MD; Jo Cleveland, MD, AGSF; Mia Yang, MD, MS; Jennifer Li, MD; Stephen J. Bonasera, MD 

This session will include presentations and hands-on skill stations focused on: 1) diagnosis and staging of AD, including when to consider advanced imaging and other biomarkers, 2) therapeutic choices for early AD, including monoclonal antibody therapy eligibility and exclusions, and 3) communication skills centered on the benefits and harms of new therapies integrating with what matters most to the patient. Learning Objectives: (1) diagnose and stage Alzheimer’s disease using a modern clinical, cognitive testing, imaging and biomarker based approach; (2) using the framework of the geriatric 5Ms (mind, medications, mobility, multicomplexity and matters most), analyze the benefits and risks of therapies for MCI and Mild Dementia due to AD; (3) observe and practice communication strategies to counsel patients and care partners on new therapies for AD based on what matters most.